Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection

Clinical Laboratory

Volumn 47, Issue 3-4, 2001, Pages 119-127

  Aoyagi, K ^a   Iida, K ^a   Ohue, C ^a   Matsunaga, Y ^a   Tanaka, E ^a   Kiyosawa, K ^a   Yagi, S ^a  

^a FUJIREBIO INC   (Japan)

Author keywords

Blood donor screening; Enzyme immunoassay; HCV RNA; Hepatitis C virus core antigen; PCR

Indexed keywords

RECOMBINANT ANTIGEN; VIRUS ANTIGEN; VIRUS RNA;

ANALYTIC METHOD; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; GENE AMPLIFICATION; GENE TECHNOLOGY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; NORMAL HUMAN; PERFORMANCE; REPRODUCIBILITY; RNA ANALYSIS; SCREENING; SEROCONVERSION; SUPERINFECTION;

CASE-CONTROL STUDIES; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOENZYME TECHNIQUES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0035079819     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA
2. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
3. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis
4. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays
5. The risk of transfusion-transmitted viral infections
6. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection
7. A case of posttransfusion hepatitis C caused by a blood donated before an appearance of HCV antibody in the early period of hepatitis C virus infection
8. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion
9. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
10. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV, and HIV
11. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
12. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7)
13. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay
14. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
15. Detection of hepatitis C virus core protein circulating within different virus particle populations
16. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts
17. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins
18. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients
19. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA
20. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method
21. Seroconversion of HIV, HCV, and HBV in blood donors in 1996 -risk of virus transmission by blood products in Germany
22. Estimated risk of transmission of hepatitis C virus by blood transfusion
23. Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C